Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of HSK44459 Tablets in adult Behçet's disease
CTR20252655Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in Behçet's disease (BD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jul 2025; status: active.
02
Drugs
HSK44459
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on CTR20252655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252655.